DIA Europe 2019 has ended
avatar for Wendy Zwolenski-Lambert

Wendy Zwolenski-Lambert

Novartis Pharma AG, Switzerland
Director, Regulatory Affairs CMC Strategy and Policy
Wendy Zwolenski-Lambert Wendy Zwolenski-Lambert is the Efpia topic lead on the ICH Q13 Continuous Manufacturing Expert Working Group. Following a decade working in medical devices and drug delivery systems, she moved to biopharmaceutical manufacturing of monoclonal antibodies. She has broad experience in number functional areas including Analytical Chemistry, Process Engineering, Validation, and Quality in a number of pharmaceutical companies. She is currently employed with Novartis AG in Basel, Switzerland where she recently moved from Novartis Manufacturing Science & Technology to Regulatory CMC. Ms. Zwolenski holds degrees in Biology and Chemistry as well as a graduate degree in Regulatory Affairs.

My Speakers Sessions

Thursday, February 7

10:45 CET